Vasoconstriction and vasodilation in erectile physiology

Current Urology Reports

Volumn 3, Issue 6, 2002, Pages 477-483

  Mills, Thomas M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Erectile Dysfunction; Mean Arterial Pressure; Penile Erection; Rolipram; Vasoactive Intestinal Peptide

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RHO KINASE; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE;

DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; IMPOTENCE; MALE; PATHOPHYSIOLOGY; PENIS; PHYSIOLOGY; REVIEW; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION;

HUMANS; IMPOTENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PENIS; PROTEIN-SERINE-THREONINE KINASES; VASOCONSTRICTION; VASODILATION;

EID: 0242489617     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-002-0101-9     Document Type: Article

References (46)

1. Andersson KE: Pharmacology of erectile function and dysfunction. Urol Clin North Am 2001, 28:233–247. DOI: 10.1016/S0094-0143(05)70134-8
2. Andersson KE: Pharmacology of penile erection. Pharmacol Rev 2001, 53:417–450. An extremely throrough and very well-documented review of the pathways and agents that regulate the erectile response.
3. Andersson KE: Neurophysiology/pharmacology of erection. Int J Impot Res 2001, 13(Suppl 5):S8-S17.
4. Naylor AM: Endogenous neurotransmitters mediating penile erection. Br J Urol 1998, 81:424–431.
5. Kim NN, Goldstein I, Moreland RB, Traish AM: Alphaadrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum. Int J Impot Res 2000, 12(Suppl 1):S26-S36. DOI: 10.1038/sj.ijir.3900504
6. Andersson KE, Hedlund P, Alm P: Sympathetic pathways and adrenergic innervation of the penis. Int J Impot Res 2000, 12(Suppl 1):S5–12. DOI: 10.1038/sj.ijir.3900513
7. Traish A, Kim NN, Moreland RB, Goldstein I: Role of alpha adrenergic receptors in erectile function. Int J Impot Res 2000, 12(Suppl 1):S48-S63. DOI: 10.1038/sj.ijir.3900506
8. Mills T, Pollock DM, Lewis RW, et al.: Endothelin-1 induced vasoconstriction is inhibited during erection in rats. Am J Physiol Regul Integr Comp Physiol 2001, 281:R476-R483.
9. Dai Y, Pollock DM, Lewis RW, et al.: Receptor-specific influence of endothelin-1 in the erectile response of the rat. Am J Physiol Regul Integr Comp Physiol 2000, 279:R25-R30.
10. Jong MY, Kang TM, Lee S: The effects of nitric oxide on the endothelin-1-induced intracellular calcium increases in smooth muscle cells of human corpus cavernosum [abstract]. Paper presented at the 7th Biennial Asia-Pacific Meeting on Impotence. Tokyo, Japan. October 26–30, 1999.
11. Giraldi A, Serels S, Autieri M, et al.: Endothelin-1 as a putative modulator of gene expression and cellular physiology in cultured human corporal smooth muscle cells. J Urol 1998, 160:1856–1862. DOI: 10.1016/S0022-5347(01)62432-7
12. Rossi P, Menchini Fabris F, Fiorini I, et al.: Comparison between plasma concentrations of testosterone nitric oxide and endothelin-1 in penile and brachial venous blood: preliminary results in men with psychogenic impotence. Biomed Pharmacother 1998, 52:308–310. DOI: 10.1016/S0753-3322(98)80026-7
13. Redmond EM, Cahill PA, Hodges R, et al.: Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J Cell Physiol 1996, 166:469–479. DOI: 10.1002/(SICI)1097-4652(199603)166:3<469::AID-JCP1>3.0.CO;2-N
14. Pollock DM, Tasker AS: Endothelin receptors and receptor antagonists. In Endothelin Receptors and Signaling Mechanisms. Edited by Pollock DM, Highsmith RF. Berlin: Springer-Verlag; 1998:3–15.
15. Somlyo AP, Wu X, Walker LA, Somlyo AV: Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 1999, 134:201–234.
16. Somlyo AP, Somlyo AV: Signal transduction by G-proteins rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000, 522:177–185. An excellent overall review that demonstrates the importance of the RhoA/ Rho-kinase calcium sensitization pathway in smooth muscle physiology. DOI: 10.1111/j.1469-7793.2000.t01-2-00177.x
17. DeFeo T, Morgan K: Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. J Physiol 1985, 369:269–292.
18. Stief CG, Noack T, Andersson KE: Signal transduction in cavernous smooth muscle. World J Urol 1997, 15:27–31. DOI: 10.1007/BF01275153
19. Burnett AL: The role of nitric oxide in the physiology of erection. Biol Reprod 1995, 52:485–489. DOI: 10.1095/biolreprod52.3.485
20. Tamura M, Kagawa S, Tsuruo Y, et al.: Localization of NADPH diaphorase and vasoactive intestinal polypeptide-containing neurons in the efferent pathway to the rat corpus cavernosum. Eur Urol 1997, 32:100–104.
21. McMahon CG: A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. Int J Impot Res 1996, 8:233–236.
22. Champion HC, Wang R, Santiago JA, et al.: Comparison of responses to adrenomedullin and calcitonin generelated peptide in the feline erection model. J Androl 1997, 18:513–521.
23. Truss MC, Becker AJ, Thon WF, et al.: Intracavernous calcitonin gene-related peptide plus prostaglandin E1: possible alternative to penile implants in selected patients. Eur Urol 1994, 26:40–45.
24. Djamilian M, Stief CG, Kuczyk M, Jonas U: Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction. J Urol 1993, 149:1296–1298.
25. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, et al.: Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000, 275:21722–21729. DOI: 10.1074/jbc.M000753200
26. Sanez De Tejada I: Molecular mechanisms for the regulation of penile smooth muscle. Int J Impot Res 2002, 14(Suppl 1):S6-S10. DOI: 10.1038/sj.ijir.3900790
27. Suh JK, Mun KH, Cho CK, et al.: Effect of vasoactive intestinal peptide and acetylcholine on penile erection in the rat in vivo. Int J Impot Res 1995, 7:111–118.
28. Bivalacqua TJ, Champion HC, Rajasekaran MA, et al.: Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4). J Urol 1999, 162:1848–1855. DOI: 10.1016/S0022-5347(05)68249-3
29. Burnett AL, Nelson RJ, Calvin DC, et al.: Nitric oxidedependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 1996, 2:288–296.
30. Goldstein I, Lue TF, Padma-Nathan H, et al.: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Engl J Med 1998, 338:1397–1404. DOI: 10.1056/NEJM199805143382001
31. Mills TM, Chitaley K, Wingard CJ, et al.: Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 2001, 91:1269–1273.
32. Chitaley K, Webb RC, Mills TM: RhoA/Rho-kinase: a novel player in the regulation of penile erection. Int J Impot Res 2001, 13:67–72. DOI: 10.1038/sj.ijir.3900647
33. Chitaley K, Wingard C, Clinton Webb R, et al.: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001, 7:119–122. The first demonstration of the importance of the RhoA/Rho-kinase pathway in the erectile response of the mammalian penis. These studies showed that both RhoA and Rho-kinase proteins are present in rat erectile tissue. Furthermore, through the use of NOS inhibitors and guanylate cyclase, the experiments showed that inhibition of Rho-kinase leading to erection did not activate NO/cGMPdependent vasorelaxation. DOI: 10.1038/83258
34. Rees RW, Ziessen T, Ralph DJ, et al.: Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res 2002, 14:1–7. DOI: 10.1038/sj.ijir.3900814
35. Rees RW, Ralph DJ, Royle M, et al.: Y-27632, an inhibitor of Rho-kinase antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 2001, 133:455–458. DOI: 10.1038/sj.bjp.0704124
36. Wingard C, Lewis R, Mills T: Erection and NO override the vasoconstrictor effect of alpha adrenergic stimulation in the rat penile vasculature. Int J Impot Res 2001, 13(Suppl 5):212–220. DOI: 10.1038/sj.ijir.3900688
37. Reilly CM, Stopper VS, Mills TM: Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 1997, 18:26–31.
38. Chitaley K, Webb RC: Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension 2002, 39:438–442. DOI: 10.1161/hy02t2.102960
39. Mills TM, Chitaley K, Lewis RW, Webb RC: Nitric oxide inhibits RhoA/Rho-kinase signaling to cause erection. Eur J Pharmacol 2002, 439:173–174. These studies support the hypothesis that an important action of NO leading to erection is the inhibition of the RhoA/Rho-kinase pathway. DOI: 10.1016/S0014-2999(02)01408-5
40. Chitaley K, Webb RC, Mills TM: The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of Rho-kinase and their potential role in the erectile response. Int J Impot Res 2002, In press.
41. Mills TM, Chitaley K, Lewis R: Vasoconstrictors in erectile physiology. Int J Impot Res 2001, 13(Suppl 5):S1-S5.
42. Chitaley K, Webb RC, Dorrance AM, Mills TM: Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001, 13(Suppl 5):S16-S20. DOI: 10.1038/sj.ijir.3900773
43. Dai Y, Lewis RW, Stopper VS, Mills TM: Effects of castration and testosterone replacement on veno-occlusion during penile erection in the rat. Asian J Androl 1999, 1:53–59.
44. Mills TM, Lewis RW: The role of androgens in the erectile response: a 1999 perspective. Mol Urol 1999, 3:75–80.
45. Mills TM, Dai Y, Stopper VS, Lewis RW: Androgenic maintenance of the erectile response in the rat. Steroids 1998, 64:605–609. DOI: 10.1016/S0039-128X(99)00040-9
46. Uehata M, Ishizaki T, Sagoh H, et al.: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990–994. DOI: 10.1038/40187